Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1832588 (PSS)
 2,979 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Prenatal stress alters the endocrine as well as the behavioral responses of rodents. Because of the reductions in both estradiol-induced and ether-induced prolactin (Prl) release reported in prenatally-stressed (P-S) rats, we were interested in whether prenatal stress might also modify the prolactin response of male and female rats to a moderate stressor in adulthood, viz., restraint stress. Timed-mated Sprague-Dawley females were exposed to a daily regimen of heat and restraint stress from days 15-22 of gestation. Control animals remained undisturbed throughout pregnancy. In adulthood, half of the male and female P-S and Control offspring were stressed by placing them in a Plexiglas restraint tube for 60 min (restraint stressed; S; referred to as P-SS and CS, respectively). The remaining half of the P-S and Control animals were left undisturbed (these were nonrestrained; NR; referred to as P-SNR and CNR, respectively). Blood samples (decapitation) were then collected from all animals and plasma was assayed for Prl content. P-SNR and CNR males did not differ in baseline Prl levels, nor did P-SNR and CNR females. Following the restraint stress in adulthood, P-SS males as well as PSS females exhibited significantly less of an increase in Prl relative to CS males and CS females, respectively. In addition, baseline Prl levels differed between the sexes, with females--regardless of prenatal condition--having higher plasma Prl levels than males. These sex differences were no longer evident following restraint stress. These data, in combination with other work in P-S animals in the areas of Prl release and stress responses, demonstrate that prenatal stress renders the rat less hormonally (Prl) responsive to stress, with the effect being more pronounced in the female.
 ...
PMID:Alterations in stress-induced prolactin release in adult female and male rats exposed to stress, in utero. 278 Aug 69

The implantable cuff electrode is an effective neuroprosthetic device in current nerve tissue engineering. However, biocompatibility and stability are still a serious dispute in terms of in vivo function and continuous monitoring. In this regard, assessing the host's biological response to biomaterials is one of the key factors of chronic implantation. In this article, we analyzed the peripheral nerve specific-biological responses to the application of multi-functional hydrogel-coated electrodes. The surface of the cuff electrode was modified using a multifunctional hydrogel composed of PEG hydrogel, cyclosporin A(CsA)-microsphere(MS) and electrodeposited PEDOT:PSS. Through our approach, we have found that the multifunctional hydrogel coatings improve the neural electrode function, such as peak-to-peak amplitude increase. Additionally, the multifunctional hydrogel coated electrodes exhibited improved biocompatibility, such as reduced apoptotic properties and increased axonal myelination. Furthermore, 12 genes (BDNF, Gfra1, IL-6, Sox 10, S100B, P75 NTR , GAP43, MBP, MPZ, NrCAM, NE-FL, CB1) were upregulated at 5 weeks post-implant. Finally, double immunofluorescence revealed the effect of endocannabinoid system on neuroprotective properties and tissue remodeling of peripheral nerves during cuff electrode implantation. These results clearly confirmed that multifunctional hydrogel coatings could improve electrode function and biocompatibility by enhancing neuroprotective properties, which may provide a valuable paradigm for clinical neurology application.
 ...
PMID:Biological assessments of multifunctional hydrogel-decorated implantable neural cuff electrode for clinical neurology application. 2912 34